These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 21676896

  • 1. Global map of physical interactions among differentially expressed genes in multiple sclerosis relapses and remissions.
    Tuller T, Atar S, Ruppin E, Gurevich M, Achiron A.
    Hum Mol Genet; 2011 Sep 15; 20(18):3606-19. PubMed ID: 21676896
    [Abstract] [Full Text] [Related]

  • 2. Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapse.
    Achiron A, Feldman A, Mandel M, Gurevich M.
    Ann N Y Acad Sci; 2007 Jun 15; 1107():155-67. PubMed ID: 17804543
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
    Honardoost MA, Kiani-Esfahani A, Ghaedi K, Etemadifar M, Salehi M.
    Gene; 2014 Jul 10; 544(2):128-33. PubMed ID: 24792898
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy.
    Singh MK, Scott TF, LaFramboise WA, Hu FZ, Post JC, Ehrlich GD.
    J Neurol Sci; 2007 Jul 15; 258(1-2):52-9. PubMed ID: 17467740
    [Abstract] [Full Text] [Related]

  • 17. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.
    Pulkkinen K, Luomala M, Kuusisto H, Lehtimäki T, Saarela M, Jalonen TO, Elovaara I.
    Acta Neurol Scand; 2004 May 15; 109(5):342-7. PubMed ID: 15080861
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.